Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.2.30 (
PARP
)
13,611
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
CMTM5
(CKLF-like MARVEL transmembrane domain-containing member 5) exhibits tumor inhibition activity with frequent epigenetic inactivation in various tumor cell lines including cervical carcinoma (CC) cells. In this paper, we examined the function of
CMTM5
-v1 (the primary RNA splicing form) in both HeLa and SiHa cells. Overexpression of
CMTM5
-v1 in both cells can induce apoptosis, but the effects are more obvious in SiHa than that in HeLa. In SiHa cells, restoration of
CMTM5
-v1 caused disruption of mitochondrial transmembrane potential, release of cytochrome c, activation of caspase3 and cleavage of
PARP
. General caspase inhibitor almost prevented apoptosis of SiHa cells, suggesting that
CMTM5
-v1 induces apoptosis mainly through caspase-dependent pathway. These findings verify that
CMTM5
-v1 inhibits the growth of CC cell lines via inducing apoptosis.
...
PMID:CMTM5-v1 induces apoptosis in cervical carcinoma cells. 1912 4